NCT00060957View on ClinicalTrials.gov

Botulinum Toxin (BOTOX) for Cerebral Palsy

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 1997

Primary Completion Date

June 30, 2002

Conditions
Cerebral PalsyMuscle Spasticity
Interventions
DRUG

Botulinum toxin type A

Trial Locations (1)

98105

Children's Hospital and Regional Medical Center, Seattle

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00060957 - Botulinum Toxin (BOTOX) for Cerebral Palsy | Biotech Hunter | Biotech Hunter